4//SEC Filing
TRENARY C RUSSELL III 4
Accession 0001209191-21-046011
CIK 0001649989other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 5:26 PM ET
Size
5.7 KB
Accession
0001209191-21-046011
Insider Transaction Report
Form 4
TRENARY C RUSSELL III
DirectorCEO and President
Transactions
- Award
Stock Option (Right to Buy)
2021-07-06+4,000,000→ 4,000,000 totalExercise: $2.42Exp: 2031-07-06→ Common Stock (4,000,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on July 6, 2022, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001227307
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 5:26 PM ET
- Size
- 5.7 KB